CH in children with SCD and Asciminib for CML in the ASC4FIRST trial

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Alexander Bick and Jorge Cortes on their latest papers published in Blood . Dr. Cortes, the current EIC of Blood Global Hematology discusses " Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial " wherein the planned secondary analysis showed a further efficacy advantage and a consistently favorable safety profile for asciminib relative to investigator-selected TKIs, especially second-generation TKIs. Dr. Bick discusses " Increased prevalence of clonal hematopoiesis in children with sickle cell disease " where targeted sequencing for CH mutations in 2318 children with SCD and 2957 controls and found that children with SCD have a higher prevalence of CH, and majority of CH cases identified were very small “micro-CH” clones, more work is needed to define the clinical significance of these clones.

You can listen to CH in children with SCD and Asciminib for CML in the ASC4FIRST trial online on Radio and Podcast. Open the player on this page to stream the available audio.

CH in children with SCD and Asciminib for CML in the ASC4FIRST trial is an episode from Blood Podcast by American Society of Hematology.

This episode is 13:35 long.

This episode was published on Mar 26, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Blood Podcast when more episodes are available from the podcast feed.